1Heathcote EJ.Management of primary biliary cirrhosis:theAmerican Association for the Study of Liver Disease practiceguidelines.Hepatology,2000,31(4):1005-1013. 被引量：1
2Poupon RE,Bonnand AM,Chretien Y,et al.Ten-year surviv-al in ursodeoxycholic acid-treated patients with primary biliar-y cirrhosis:the UDCA-PBC Study Group.Hepatology,1999,29(6):1668-1671. 被引量：1
3Lazaridis KN,Gores GJ,Lindor KD.Ursodexycholic acid me-chanisms of action and clinical use in hepatobiliary disorders.J Hepatol,2001,35(1):134-146. 被引量：1
4Poupon R,Poupon RE.Treatment of primary biliary cirrho-sis.Baillieres Best Pract Res Clin Gastroenterol,2000,14(4):615-628. 被引量：1
5Prince M,Chetwynd A,Newman W,et al.Survival and symp-tom progression in a geographically based cohort of patientswith primary biliary cirrhosis:follow-up for up to 28years.Gastroenterology,2002,123(4):1044-1051. 被引量：1
6Jorgensen R,Angulo P,Dickson R,et al.Results of long-term ursodiol treatment for patients with primary biliary cir-rhosis.Am Gastroenterol,2002,97(10):2647-2650. 被引量：1
9RAOUL POUPON. Primary biliary cirrhosis: A 2010 update [J]. Journal of Hepatology, 2010, 52:745-758. 被引量：1
10HEATHCOTE EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines [J] . Hepatology, 2000, 31:1005-1013. 被引量：1
6Corpechot C, Chretien Y, Chazouineres O, et al. Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis[J]. J Hepatol, 2010, 53(1) : 162-169. 被引量：1
7Nguyen DL, Juran BD, Lazaridis KN, et al. Primary biliary cirrhosis [J]. Best Pract Res Clin Gastroenterol, 2010,24(5) : 647-654. 被引量：1
8Silveira MG, Brunt EM, Heathcote J, et al. American association forthe study of liver diseases endpoints conference: design and endpointsfor clinical trials in primary biliary cirrhosis [ J ]. J Hepatol, 2010,52(1) : 349-359. 被引量：1
